Cargando…
Abnormal microRNA expression in the course of hematological malignancies
Research on the carcinogenesis process is currently focused primarily on understanding its genetic basis and molecular abnormalities that may be predictive factors and therapeutic targets. It was clearly confirmed recently that microRNAs are involved in the mechanisms of leukocyte development, diffe...
Autores principales: | Szymczyk, Agnieszka, Macheta, Arkadiusz, Podhorecka, Monika |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6183594/ https://www.ncbi.nlm.nih.gov/pubmed/30349361 http://dx.doi.org/10.2147/CMAR.S174476 |
Ejemplares similares
-
Assessment of microRNA expression in leukemic cells as predictors of sensitivity to purine nucleoside analogs, fludarabine and cladribine, in chronic lymphocytic leukemia patients
por: Szymczyk, Agnieszka, et al.
Publicado: (2019) -
Assessment of micro RNAs expression in leukemic cells as prognostic markers in chronic lymphocytic leukemia: micro RNAs can predict survival in a course of the disease
por: Szymczyk, Agnieszka, et al.
Publicado: (2018) -
Target Therapy in Hematological Malignances: New Monoclonal Antibodies
por: Podhorecka, Monika, et al.
Publicado: (2014) -
The Neutrophil to Lymphocyte and Lymphocyte to Monocyte Ratios as New Prognostic Factors in Hematological Malignancies – A Narrative Review
por: Stefaniuk, Paulina, et al.
Publicado: (2020) -
Assessment of red blood cell distribution width as a prognostic marker in chronic lymphocytic leukemia
por: Podhorecka, Monika, et al.
Publicado: (2016)